Topography of cortical thinning associated with white matter hyperintensities in Parkinson's disease

Parkinsonism and Related Disorders

Volumn 21, Issue 4, 2015, Pages 372-377

  Ham, Jee Hyun ^a   Yun, Hyuk Jin ^b   Sunwoo, Mun Kyung ^c   Hong, Jin Yong ^d   Lee, Jong Min ^b   Sohn, Young H ^a   Lee, Phil Hyu ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Hanyang University   (South Korea)

^c Bundang Jesaeng Hospital   (South Korea)

^d Yonsei University Wonju College of Medicine   (South Korea)

Author keywords

Cortical thinning; Parkinson's disease; White matter hyperintensities

Indexed keywords

AGED; ANTERIOR CINGULATE; ARTICLE; CAPSULA INTERNA; CAUDATE NUCLEUS; CEREBELLUM; COGNITION; CONTROLLED STUDY; CORTICAL THICKNESS (BRAIN); COWAT TEST; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; FEMALE; FOREBRAIN; FRONTAL LOBE; GLOBUS PALLIDUS; HUMAN; IMAGE ANALYSIS; INFERIOR PARIETAL LOBULE; INFERIOR TEMPORAL GYRUS; MAJOR CLINICAL STUDY; MALE; MEDULLA OBLONGATA; MESENCEPHALON; MIDDLE TEMPORAL GYRUS; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; ORBITAL CORTEX; PARKINSON DISEASE; PONS; PREFRONTAL CORTEX; PRIMARY MOTOR CORTEX; PRIORITY JOURNAL; PUTAMEN; STROOP TEST; SUPERIOR TEMPORAL GYRUS; TEMPORAL LOBE; THALAMUS; WHITE MATTER; ENCEPHALOMALACIA; EXECUTIVE FUNCTION; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

AGED; EXECUTIVE FUNCTION; FEMALE; FRONTAL LOBE; HUMANS; LEUKOMALACIA, PERIVENTRICULAR; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PARKINSON DISEASE; WHITE MATTER;

EID: 84925369178     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2015.01.015     Document Type: Article

References (31)

1. Aarsland D., Andersen K., Larsen J.P., Lolk A., Nielsen H., Kragh-Sorensen P. Risk of dementia in Parkinson's disease: a community-based, prospective study. Neurology 2001, 56(6):730-736.
2. Aarsland D., Bronnick K., Larsen J.P., Tysnes O.B., Alves G. Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study. Neurology 2009, 72(13):1121-1126.
3. Emre M. Dementia associated with Parkinson's disease. Lancet Neurol 2003, 2(4):229-237.
4. Compta Y., Parkkinen L., O'Sullivan S.S., Vandrovcova J., Holton J.L., Collins C., et al. Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?. Brain 2011, 134(Pt 5):1493-1505.
5. Prasad K., Wiryasaputra L., Ng A., Kandiah N. White matter disease independently predicts progression from mild cognitive impairment to Alzheimer's disease in a clinic cohort. Dement Geriatr Cogn Disord 2011, 31(6):431-434.
6. Fazekas F., Chawluk J.B., Alavi A., Hurtig H.I., Zimmerman R.A. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol 1987, 149(2):351-356.
7. Bombois S., Debette S., Delbeuck X., Bruandet A., Lepoittevin S., Delmaire C., et al. Prevalence of subcortical vascular lesions and association with executive function in mild cognitive impairment subtypes. Stroke 2007, 38(9):2595-2597.
8. van den Heuvel D.M., ten Dam V.H., de Craen A.J., Admiraal-Behloul F., Olofsen H., Bollen E.L., et al. Increase in periventricular white matter hyperintensities parallels decline in mental processing speed in a non-demented elderly population. JNeurol Neurosurg Psychiatry 2006, 77(2):149-153.
9. Delano-Wood L., Abeles N., Sacco J.M., Wierenga C.E., Horne N.R., Bozoki A. Regional white matter pathology in mild cognitive impairment: differential influence of lesion type on neuropsychological functioning. Stroke 2008, 39(3):794-799.
10. Soriano-Raya J.J., Miralbell J., Lopez-Cancio E., Bargallo N., Arenillas J.F., Barrios M., et al. Deep versus periventricular white matter lesions and cognitive function in a community sample of middle-aged participants. JInt Neuropsychol Soc 2012, 18(5):874-885.
11. Lee S.J., Kim J.S., Yoo J.Y., Song I.U., Kim B.S., Jung S.L., et al. Influence of white matter hyperintensities on the cognition of patients with Parkinson disease. Alzheimer Dis Assoc Disord 2010, 24(3):227-233.
12. Beyer M.K., Aarsland D., Greve O.J., Larsen J.P. Visual rating of white matter hyperintensities in Parkinson's disease. Mov Disord 2006, 21(2):223-229.
13. Slawek J., Wieczorek D., Derejko M., Dubaniewicz M., Brockhuis B., Sitek E., et al. The influence of vascular risk factors and white matter hyperintensities on the degree of cognitive impairment in Parkinson's disease. Neurol Neurochir Pol 2008, 42(6):505-512.
14. Ha S.Y., Youn Y.C., Kim S., Hsiung G.Y., Ahn S.W., Shin H.W., et al. Avoxel-based morphometric study of cortical gray matter volume changes in Alzheimer's disease with white matter hyperintensities. JClin Neurosci 2012, 19(11):1506-1510.
15. Seo S.W., Ahn J., Yoon U., Im K., Lee J., Tae Kim S., et al. Cortical thinning in vascular mild cognitive impairment and vascular dementia of subcortical type. JNeuroimaging 2010, 20(1):37-45.
16. Hughes A.J., Daniel S.E., Kilford L., Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. JNeurol Neurosurg Psychiatry 1992, 55(3):181-184.
17. Kang Y., Na D. Seoul neuropsychological Screening battery 2003, Republic of Korea Human Brain Research & Consulting Corp, Incheon.
18. Scheltens P., Barkhof F., Leys D., Pruvo J.P., Nauta J.J., Vermersch P., et al. Asemiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. JNeurol Sci 1993, 114(1):7-12.
19. Collins D.L., Neelin P., Peters T.M., Evans A.C. Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space. JComput Assist Tomogr 1994, 18(2):192-205.
20. MacDonald D., Kabani N., Avis D., Evans A.C. Automated 3-D extraction of inner and outer surfaces of cerebral cortex from MRI. Neuroimage 2000, 12(3):340-356.
21. Robbins S., Evans A.C., Collins D.L., Whitesides S. Tuning and comparing spatial normalization methods. Med Image Anal 2004, 8(3):311-323.
22. Im K., Lee J.M., Yoon U., Shin Y.W., Hong S.B., Kim I.Y., et al. Fractal dimension in human cortical surface: multiple regression analysis with cortical thickness, sulcal depth, and folding area. Hum Brain Mapp 2006, 27(12):994-1003.
23. Wen W., Sachdev P.S., Chen X., Anstey K. Gray matter reduction is correlated with white matter hyperintensity volume: a voxel-based morphometric study in a large epidemiological sample. Neuroimage 2006, 29(4):1031-1039.
24. Jones T.A., Schallert T. Subcortical deterioration after cortical damage: effects of diazepam and relation to recovery of function. Behav Brain Res 1992, 51(1):1-13.
25. Cowey A., Alexander I., Stoerig P. Transneuronal retrograde degeneration of retinal ganglion cells and optic tract in hemianopic monkeys and humans. Brain 2011, 134(Pt 7):2149-2157.
26. Kim K.W., MacFall J.R., Payne M.E. Classification of white matter lesions on magnetic resonance imaging in elderly persons. Biol Psychiatry 2008, 64(4):273-280.
27. Fazekas F., Kleinert R., Offenbacher H., Schmidt R., Kleinert G., Payer F., et al. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology 1993, 43(9):1683-1689.
28. de Leeuw F.E., de Groot J.C., Bots M.L., Witteman J.C., Oudkerk M., Hofman A., et al. Carotid atherosclerosis and cerebral white matter lesions in a population based magnetic resonance imaging study. JNeurol 2000, 247(4):291-296.
29. Sachdev P., Parslow R., Salonikas C., Lux O., Wen W., Kumar R., et al. Homocysteine and the brain in midadult life: evidence for an increased risk of leukoaraiosis in men. Arch Neurol 2004, 61(9):1369-1376.
30. Unal-Cevik I., Gursoy-Ozdemir Y., Yemisci M., Lule S., Gurer G., Can A., et al. Alpha-synuclein aggregation induced by brief ischemia negatively impacts neuronal survival invivo: a study in [A30P]alpha-synuclein transgenic mouse. JCereb Blood Flow Metab 2011, 31(3):913-923.
31. DeCarli C., Fletcher E., Ramey V., Harvey D., Jagust W.J. Anatomical mapping of white matter hyperintensities (WMH) exploring the relationships between periventricular WMH, deep WMH, and total WMH burden. Stroke 2005, 36(1):50-55.